408 related articles for article (PubMed ID: 34237823)
1. Clinical and genetic characteristics of Korean autosomal dominant polycystic kidney disease patients.
Oh YK; Park HC; Ryu H; Kim YC; Oh KH
Korean J Intern Med; 2021 Jul; 36(4):767-779. PubMed ID: 34237823
[TBL] [Abstract][Full Text] [Related]
2. Bilineal inheritance of pathogenic PKD1 and PKD2 variants in a Czech family with autosomal dominant polycystic kidney disease - a case report.
Elisakova V; Merta M; Reiterova J; Baxova A; Kotlas J; Hirschfeldova K; Obeidova L; Tesar V; Stekrova J
BMC Nephrol; 2018 Jul; 19(1):163. PubMed ID: 29973168
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel PKD1 and PKD2 mutations in Korean patients with autosomal dominant polycystic kidney disease.
Choi R; Park HC; Lee K; Lee MG; Kim JW; Ki CS; Hwang YH; Ahn C
BMC Med Genet; 2014 Dec; 15():129. PubMed ID: 25491204
[TBL] [Abstract][Full Text] [Related]
4. PKD2-Related Autosomal Dominant Polycystic Kidney Disease: Prevalence, Clinical Presentation, Mutation Spectrum, and Prognosis.
Cornec-Le Gall E; Audrézet MP; Renaudineau E; Hourmant M; Charasse C; Michez E; Frouget T; Vigneau C; Dantal J; Siohan P; Longuet H; Gatault P; Ecotière L; Bridoux F; Mandart L; Hanrotel-Saliou C; Stanescu C; Depraetre P; Gie S; Massad M; Kersalé A; Séret G; Augusto JF; Saliou P; Maestri S; Chen JM; Harris PC; Férec C; Le Meur Y
Am J Kidney Dis; 2017 Oct; 70(4):476-485. PubMed ID: 28356211
[TBL] [Abstract][Full Text] [Related]
5. Coexistence of autosomal dominant polycystic kidney disease type 1 and hereditary renal hypouricemia type 2: A model of early-onset and fast cyst progression.
Peces R; Mena R; Peces C; Cuesta E; Selgas R; Barruz P; Lapunzina P; Nevado J
Clin Genet; 2020 Jun; 97(6):857-868. PubMed ID: 32166738
[TBL] [Abstract][Full Text] [Related]
6. Genetics May Predict Effectiveness of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease.
Sekine A; Hoshino J; Fujimaru T; Suwabe T; Mizuno H; Kawada M; Hiramatsu R; Hasegawa E; Yamanouchi M; Hayami N; Mandai S; Chiga M; Kikuchi H; Ando F; Mori T; Sohara E; Uchida S; Sawa N; Takaichi K; Ubara Y
Am J Nephrol; 2020; 51(9):745-751. PubMed ID: 32784291
[TBL] [Abstract][Full Text] [Related]
7. Effect of tolvaptan on renal involvement in patients with autosomal dominant polycystic kidney disease according to different gene mutations.
Moriyama T; Nakayama Y; Soejima M; Yokota Y; Ota K; Ito S; Kodama G; Nakamura N; Kurokawa Y; Yano J; Ueda U; Takamiya Y; Kaida Y; Hazama T; Shibata R; Koda Y; Fukami K
Clin Exp Nephrol; 2021 Mar; 25(3):251-260. PubMed ID: 33141305
[TBL] [Abstract][Full Text] [Related]
8. Kidney enlargement and multiple liver cyst formation implicate mutations in PKD1/2 in adult sporadic polycystic kidney disease.
Fujimaru T; Mori T; Sekine A; Mandai S; Chiga M; Kikuchi H; Ando F; Mori Y; Nomura N; Iimori S; Naito S; Okado T; Rai T; Hoshino J; Ubara Y; Uchida S; Sohara E
Clin Genet; 2018 Jul; 94(1):125-131. PubMed ID: 29520754
[TBL] [Abstract][Full Text] [Related]
9. Identification of pathological transcription in autosomal dominant polycystic kidney disease epithelia.
Friedrich S; Müller H; Riesterer C; Schüller H; Friedrich K; Wörner CL; Busch T; Viau A; Kuehn EW; Köttgen M; Hofherr A
Sci Rep; 2021 Jul; 11(1):15139. PubMed ID: 34301992
[TBL] [Abstract][Full Text] [Related]
10. A novel PKD1 variant demonstrates a disease-modifying role in trans with a truncating PKD1 mutation in patients with autosomal dominant polycystic kidney disease.
Ali H; Hussain N; Naim M; Zayed M; Al-Mulla F; Kehinde EO; Seaburg LM; Sundsbak JL; Harris PC
BMC Nephrol; 2015 Mar; 16():26. PubMed ID: 25880449
[TBL] [Abstract][Full Text] [Related]
11. Targeted Next Generation Sequencing Revealed Novel Variants in the
Hosseinpour M; Ardalani F; Mohseni M; Beheshtian M; Arzhangi S; Ossareh S; Najmabadi H; Nobakht A; Kahrizi K; Broumand B
Arch Iran Med; 2022 Sep; 25(9):600-608. PubMed ID: 37543885
[TBL] [Abstract][Full Text] [Related]
12. Novel PKD1 Mutations in Patients with Autosomal Dominant Polycystic Kidney Disease.
Kim H; Kim HH; Chang CL; Song SH; Kim N
Lab Med; 2021 Mar; 52(2):174-180. PubMed ID: 32816041
[TBL] [Abstract][Full Text] [Related]
13. Genetic Characteristics of Korean Patients with Autosomal Dominant Polycystic Kidney Disease by Targeted Exome Sequencing.
Kim H; Park HC; Ryu H; Kim H; Lee HS; Heo J; Lee C; Kim NKD; Park WY; Hwang YH; Lee KB; Oh KH; Oh YK; Ahn C
Sci Rep; 2019 Nov; 9(1):16952. PubMed ID: 31740684
[TBL] [Abstract][Full Text] [Related]
14. Prioritized polycystic kidney disease drug targets and repurposing candidates from pre-cystic and cystic mouse Pkd2 model gene expression reversion.
Wilk EJ; Howton TC; Fisher JL; Oza VH; Brownlee RT; McPherson KC; Cleary HL; Yoder BK; George JF; Mrug M; Lasseigne BN
Mol Med; 2023 May; 29(1):67. PubMed ID: 37217845
[TBL] [Abstract][Full Text] [Related]
15. Mutational analysis in patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD): Identification of five mutations in the PKD1 gene.
Abdelwahed M; Hilbert P; Ahmed A; Mahfoudh H; Bouomrani S; Dey M; Hachicha J; Kamoun H; Keskes-Ammar L; Belguith N
Gene; 2018 Sep; 671():28-35. PubMed ID: 29860066
[TBL] [Abstract][Full Text] [Related]
16. [Molecular genetic screening for polycystic kidney disease can be an important diagnostic tool].
Rasmussen M; Ørskov B; Skytte AB; Sunde L
Ugeskr Laeger; 2014 Jan; 176(5A):V08130496. PubMed ID: 25347339
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic Cysts in Autosomal Dominant Polycystic Kidney Disease: Prevalence and Association with PKD2 Gene Mutations.
Kim JA; Blumenfeld JD; Chhabra S; Dutruel SP; Thimmappa ND; Bobb WO; Donahue S; Rennert HE; Tan AY; Giambrone AE; Prince MR
Radiology; 2016 Sep; 280(3):762-70. PubMed ID: 27046073
[TBL] [Abstract][Full Text] [Related]
18. Genetic reduction of cilium length by targeting intraflagellar transport 88 protein impedes kidney and liver cyst formation in mouse models of autosomal polycystic kidney disease.
Shao L; El-Jouni W; Kong F; Ramesh J; Kumar RS; Shen X; Ren J; Devendra S; Dorschel A; Wu M; Barrera I; Tabari A; Hu K; Haque N; Yambayev I; Li S; Kumar A; Behera TR; McDonough G; Furuichi M; Xifaras M; Lu T; Alhayaza RM; Miyabayashi K; Fan Q; Ajay AK; Zhou J
Kidney Int; 2020 Nov; 98(5):1225-1241. PubMed ID: 32610050
[TBL] [Abstract][Full Text] [Related]
19.
Kimura T; Kawano H; Muto S; Muramoto N; Takano T; Lu Y; Eguchi H; Wada H; Okazaki Y; Ide H; Horie S
Biomolecules; 2023 Jun; 13(7):. PubMed ID: 37509056
[TBL] [Abstract][Full Text] [Related]
20. [Genetic analysis (PKD2) of autosomal dominant polycystic kidney disease].
Gómez PF; Moro EC; García-Cosmes P; Sarmiento RG; Romo JM
Nefrologia; 2009; 29(6):562-8. PubMed ID: 19936001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
